Online first
Original article
Published online: 2024-09-30
Late gadolinium enhancement in aortic stenosis: Is it an indication to surgical treatment in asymptomatic patients?
Pubmed: 39377618
Abstract
Not available
References
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed). 2022; 75(6): 524.
- Treibel TA, Kozor R, Schofield R, et al. Reverse myocardial remodeling following valve replacement in patients with aortic stenosis. J Am Coll Cardiol. 2018; 71(8): 860–871.
- Treibel TA, Scully PR, Moon JC. Myocardial hypertrophy, matrix expansion, and focal scar: progression and regression in aortic stenosis. Circ Cardiovasc Imaging. 2018; 11(6): e007975.
- Treibel T, López B, González A, et al. Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients. Eur Heart J. 2017; 39(8): 699–709.
- Bohbot Y, Renard C, Manrique A, et al. Usefulness of cardiac magnetic resonance imaging in aortic stenosis. Circ Cardiovasc Imaging. 2020; 13(5): e010356.
- Papanastasiou CA, Kokkinidis DG, Kampaktsis PN, et al. The prognostic role of late gadolinium enhancement in aortic stenosis: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2020; 13(2 Pt 1): 385–392.
- Moreo A, Ambrosio G, De Chiara B, et al. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging. 2009; 2(6): 437–443.
- Katbeh A, Ondrus T, Barbato E, et al. Imaging of myocardial fibrosis and its functional correlates in aortic stenosis: a review and clinical potential. Cardiology. 2018; 141(3): 141–149.
- Orłowska-Baranowska E, Baranowski R, Hryniewiecki T. Exercise test in patients with asymptomatic aortic stenosis: clinically useful or not? Pol Arch Intern Med. 2021; 131(4): 332–338.
- Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013; 15(1): 91.
- Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson. 2020; 22(1): 19.
- Dueck A, Lohr S. Robust estimation of multivariate covariance components. Biometrics. 2005; 61(1): 162–169.
- Pawlik A, Litwinowicz R, Kowalewski M, et al. The impact of sex on in-hospital and long-term mortality rates in patients undergoing surgical aortic valve replacement: The SAVR and SEX study. Kardiol Pol. 2023; 81(7-8): 754–762.
- Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975; 56(1): 56–64.
- Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis. 2006; 48(5): 326–341.
- Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur Heart J. 2005; 26(17): 1790–1796.
- Dweck MR, Joshi S, Murigu T, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011; 58(12): 1271–1279.
- Rudolph A, Abdel-Aty H, Bohl S, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol. 2009; 53(3): 284–291.
- Lee HJ, Lee H, Kim SM, et al. Diffuse myocardial fibrosis and diastolic function in aortic stenosis. JACC Cardiovasc Imaging. 2020; 13(12): 2561–2572.
- Ojrzyńska-Witek N, Marczak M, Mazurkiewicz Ł, et al. Role of cardiac magnetic resonance in heart failure of initially unknown etiology: A 10-year observational study. Kardiol Pol. 2022; 80(3): 278–285.
- Rajesh GN, Thottian JJ, Subramaniam G, et al. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis. Indian Heart J. 2017; 69(6): 742–750.
- Chin CWL, Everett RJ, Kwiecinski J, et al. Myocardial fibrosis and cardiac decompensation in aortic stenosis. JACC Cardiovasc Imaging. 2017; 10(11): 1320–1333.
- Barone-Rochette G, Piérard S, De Meester de Ravenstein C, et al. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol. 2014; 64(2): 144–154.
- Zhang C, Liu J, Qin S. Prognostic value of cardiac magnetic resonance in patients with aortic stenosis: A systematic review and meta-analysis. PLoS One. 2022; 17(2): e0263378.
- Castrichini M, Vitrella G, De Luca A, et al. Clinical impact of myocardial fibrosis in severe aortic stenosis. Eur Heart J Suppl. 2021; 23(Suppl E): E147–E150.
- Musa TA, Treibel TA, Vassiliou VS, et al. Myocardial scar and mortality in severe aortic stenosis. Circulation. 2018; 138(18): 1935–1947.
